At 11:00 a.m.; the stock was at Rs 626.50, down 0.65 per cent, on the BSE. It fell 1.43 per cent to touch intraday low of Rs 621.55 in trad...

Ranbaxy Laboratories Ltd has been barred by from exporting the antibiotic cephalosporin to Germany from its plant in central India.

Facilities of leading Indian drugmakers including Ranbaxy and Wockhardt were blacklisted by the US regulator last year.

USFDA has lifted the import alert for non-sterile products manufactured at Unit-VI cephalosporin facility based in Hyderabad.

Aurobindo Pharma on Wednesday said it has formed an equal joint venture with Russian healthcare equipment company Ojsc Diod.

Orchid Chemicals & Pharmaceuticals Ltd has temporality closed down its Cephalosporin API manufacturing facility in Chennai.

Orchid Chemicals and Pharmaceuticals Ltd has said its Cephalosporin API manufacturing (antibiotic) complex in Alathur, Chennai, has success...

The company sources products from local units now; may outsource manufacturing.

Parabolic Drugs will enter the primary market on June 14, 2010 to raise Rs 200 crore through its initial public offer.

Pharma company IDPL launched three new over the counter (OTC) medicines including emergency contraceptive pill Mismis.

The US Food and Drug Administration (USFDA) has found 15 manufacturing deficiencies at one of Lupin’s plant in Madhya Pradesh (MP) during t...

Otsuka Chemical India (OCIL), a wholly-owned subsidiary of Japanese company Ostuka Chemical Co. Ltd, on Friday announced commencement of pr...

Heavy buying in Venus Remedies shares continued for the second straight day Wednesday on receiving the European GMP certification for its C...

Venus Remedies has completed Phase IV of the Baddi project comprising two dedicated plants for specialty formulations.

Pharma company Wockhardt Ltd on Wednesday said it has received US Food and Drug Administration (USFDA) approval for Cefprozil tablets, an a...

Venus Remedies has said it has inaugurated the Phase II of its Rs 100 crore Baddi project.

Wockhardt Ltd on Thursday said it has received approval from USFDA for marketing antibiotic Cefotaxime sodium injection in the US market.